Clinical Trial Update: A Performance Evaluation of the Enlite Glucose Sensor to Support a Full 144 Hours(6Days) of Use [NA]

View source ↗

Summary

The study evaluates the Enlite glucose sensor for up to 144 hours (6 days) of continuous use in people with type 1 diabetes and type 2 diabetes. Results describ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Enlite glucose sensor

Snippet

Sponsor: Medtronic MiniMed, Inc. | Conditions: Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus | NA | Status: COMPLETED | Results posted: 2018-05-30